Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Lei Shi, Xin Yuan, Wei Yao, Siyu Wang, Chao Zhang, Bo Zhang, Jin‐Wen Song, Lei Huang, Zhe Xu, Junliang Fu, Yuanyuan Li, Ruonan Xu, Tiantian Li, Jinghui Dong, Jianming Cai, Genshi Li, Yunbo Xie, Ming Shi, Yonggang Li, Yu Zhang, Wei-Fen Xie, Fu‐Sheng WangSSRN 2021 · DOI

BibTeX
@misc{shi2021human,
  author = {Lei Shi and Xin Yuan and Wei Yao and Siyu Wang and Chao Zhang and Bo Zhang and Jin‐Wen Song and Lei Huang and Zhe Xu and Junliang Fu and Yuanyuan Li and Ruonan Xu and Tiantian Li and Jinghui Dong and Jianming Cai and Genshi Li and Yunbo Xie and Ming Shi and Yonggang Li and Yu Zhang and Wei-Fen Xie and Fu‐Sheng Wang},
  title = {{Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial}},
  year = {2021},
  doi = {10.2139/ssrn.3894960},
  howpublished = {SSRN},
}

Loading related content...

Figure